Nagayama Chihiro, Hamada Yuka, Kamemoto Kayoko, Hasumura Takahiro, Minegishi Yoshihiko, Matsui Yuji, Ota Noriyasu, Miyashita Masashi
Graduate School of Sport Sciences, Waseda University, Tokorozawa, Saitama, Japan.
Institute for Sport Sciences, Waseda University, Tokorozawa, Saitama, Japan.
Eur J Appl Physiol. 2025 Jun 12. doi: 10.1007/s00421-025-05833-y.
This study examined the effects of acute and chronic oral intake of tea catechins and ornithine supplementation on exercise-induced ammonia accumulation and cycling performance.
Sixteen healthy young men participated in a randomized, double-blind, cross-over, placebo-controlled study. For the acute trials, the participants consumed either tea catechins and ornithine (CO) or placebo (P) and performed cycling exercises at an intensity corresponding to 75% of the maximum heart rate for 60 min, followed by a 15-min cycling performance test. The participants continued to consume each designated supplement for 13 days. For the chronic trials, the participants repeated the same protocol as the acute trials on day 14. After a washout period, the participants changed the supplement and repeated the same protocol as above.
Plasma catechins (acute ES = 3.61; chronic ES = 2.64, p < 0.001) and ornithine (acute ES = 4.28; chronic ES = 2.25, p < 0.001) concentrations were higher in both acute and chronic CO trials than those in P trials. No differences were found in plasma ammonia concentration measured during the whole experimental period and in mean power output during the performance test among trials. Subjective fatigue during 60-min cycling was lower in both acute and chronic CO trials than those in P trials (acute ES = 0.32, chronic ES = 0.60, p < 0.001).
A single dose and 14-day oral intake of tea catechins and ornithine supplementation did not suppress exercise-induced ammonia accumulation or enhance cycling performance.
Clinical trial registration ID: UMIN000035267.
本研究探讨急性和慢性口服茶儿茶素及补充鸟氨酸对运动诱导的氨积累和骑行表现的影响。
16名健康年轻男性参与了一项随机、双盲、交叉、安慰剂对照研究。在急性试验中,参与者分别摄入茶儿茶素和鸟氨酸(CO)或安慰剂(P),并以相当于最大心率75%的强度进行60分钟的骑行运动,随后进行15分钟的骑行表现测试。参与者持续13天服用每种指定的补充剂。在慢性试验中,参与者在第14天重复与急性试验相同的方案。经过洗脱期后,参与者更换补充剂并重复上述相同方案。
急性和慢性CO试验中血浆儿茶素(急性效应量=3.61;慢性效应量=2.64,p<0.001)和鸟氨酸(急性效应量=4.28;慢性效应量=2.25,p<0.001)浓度均高于P试验。各试验在整个实验期间测得的血浆氨浓度和表现测试中的平均功率输出均无差异。急性和慢性CO试验中60分钟骑行期间的主观疲劳均低于P试验(急性效应量=0.32,慢性效应量=0.60,p<0.001)。
单次剂量和14天口服茶儿茶素及补充鸟氨酸并不能抑制运动诱导的氨积累或提高骑行表现。
临床试验注册编号:UMIN000035267。